JAN 20, 2016 12:47 PM PST

Path of Chemo Drugs Now Lit by New Peptide Tags

WRITTEN BY: Xuan Pham
Fluorescent peptide tags light the path of chemo drugs

When x-ray radiation fails or when complete surgical removal is not possible, chemotherapy is the next best available option to treat cancer cells. Although the treatment can be highly potent, doctors have limited knowledge of where the drug ends up once it is administered to the patient. To solve this problem, researchers from Ohio State University (OSU) have devised a way to tag anti-cancer drugs and follow its path in real time.
 
Tracking anti-cancer drugs in the patients has been attempted before. However, these attempts have been thwarted because organic tracker dyes dissolved too quickly before reaching the targets. Conversely, other longer-lasting tracker molecules were too toxic for the body to be of clinical use.
 
Led by Dr. Mingjun Zhang, biomedical engineering professor at OSU, the research team created a new nanoparticle tracking technology that is based on naturally occurring small peptide molecules. To the nanoparticle, the team attached a fluorescent tag that can be optically detected only once the drug is active in the body.
 
The real innovation in this new design lays in the “inherent biocompatibility” of the florescent nanoparticle. Because it is made from amino acids, the peptide causes little to no harm to the body’s cells. Furthermore, once the peptides have served its tracking purpose, the body is able to process it easily.
 
Testing the technique on doxorubicin, a commonly prescribed chemotherapy drug, the researchers noted that the fluorescence signal could be detected over long periods. Tracking this and other chemotherapy drugs could allow doctors to measure the speed and efficacy of a drug inside a patient. And because the fluorescence signal is only detectable once the drug is active, doctors can clearly trail the drug’s path and time its release.
 
As with any drug compounds, chemotherapy drugs can have different behavioral profiles in different patients. “In some people, chemotherapy can take effect in a few minutes, in others it can take hours, and there are also cases where it never takes effect,” says Prof. Zhang.
 
In the case of cancer, knowing when and where the drug acts is especially crucial, considering the fact that chemotherapy drugs are actually highly poisons to the body’s cells. Chemotherapy drugs target rapidly dividing cells and kills most cancerous cells. Unfortunately, most drugs can’t yet discriminate between cancer cells and healthy cells, so patients often experience “collateral damages” – negative side-effects from the therapy.
 
The ability to track the chemo drug in real time could greatly expand our understanding of where the drugs land and how they affect the patient, positively and negatively. The tracking technology could also be combined with targeted chemotherapies currently being developed, allowing researchers to truly minimize the collateral damages inflicted on cancer patients.
 

 
Additional source: MNT
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
SEP 29, 2020
Drug Discovery & Development
Cycling Molecules into Drug Candidates
SEP 29, 2020
Cycling Molecules into Drug Candidates
Statistics show that just 1 in 5,000 drug candidates ever makes it from the lab to the pharmacy. In a process that can t ...
OCT 15, 2020
Cardiology
Measuring Pulse Transit Time as a Replacement for the Inflatable Cuff
OCT 15, 2020
Measuring Pulse Transit Time as a Replacement for the Inflatable Cuff
Many people deal with one disease or another every day of their life. Most require checking on things like blood sugar f ...
NOV 09, 2020
Cancer
A Prognostic Expression Profile for Osteosarcoma
NOV 09, 2020
A Prognostic Expression Profile for Osteosarcoma
Tireless research goes into every cancer diagnostic tools and new therapy. Many types of cancer have made giant steps fo ...
NOV 13, 2020
Chemistry & Physics
Mid-IR Spectroscopy a Convenient, Accurate Means of Cancer Diagnosis
NOV 13, 2020
Mid-IR Spectroscopy a Convenient, Accurate Means of Cancer Diagnosis
Last Sunday, November 8, was the International Day of Radiology (IDoR 2020), an event celebrated by radiologists, techno ...
DEC 22, 2020
Cardiology
A New 3D Imaging Method for Atherosclerosis Analysis in Mice
DEC 22, 2020
A New 3D Imaging Method for Atherosclerosis Analysis in Mice
Imaging in research may not sound glamorous, but how else would news stories get those cool looking science photos for t ...
JAN 22, 2021
Clinical & Molecular DX
Breast Cancer's Nasty Nine Revealed
JAN 22, 2021
Breast Cancer's Nasty Nine Revealed
Calculating an individual’s risk of developing breast cancer isn’t easy. There’s a complex interplay b ...
Loading Comments...